SCHEDULE: AllianceBernstein Discloses 3.9% Astera Labs Stake

AllianceBernstein L.P. reported a 3.9% beneficial ownership stake in Astera Labs Inc. common stock, held for investment purposes.

Summary

• AllianceBernstein L.P. filed an Amendment No. 1 to Schedule 13G, disclosing its beneficial ownership in Astera Labs Inc. common stock.
• As of June 30, 2025, AllianceBernstein L.P. beneficially owned an aggregate of 6,391,580 shares of Astera Labs Inc. common stock.
• This ownership represents 3.9% of the class of securities.
• AllianceBernstein L.P. holds sole voting power over 6,157,426 shares and sole dispositive power over 6,390,751 shares.
• A small portion of shares, 829, are held with shared dispositive power.
• The shares were acquired solely for investment purposes on behalf of client discretionary investment advisory accounts.
• AllianceBernstein L.P. certified that the securities were not acquired for the purpose or with the effect of changing or influencing the control of Astera Labs Inc.

Sentiment

Score: 6

Explanation: The filing is a routine disclosure of beneficial ownership by a large investment adviser, indicating continued institutional interest in Astera Labs Inc. without suggesting any change in control intent. This is generally a neutral to slightly positive signal.

Positives

• The disclosure indicates continued institutional interest in Astera Labs Inc. by a major investment adviser, AllianceBernstein L.P.
• The filing explicitly states that the shares were acquired solely for investment purposes, not for control, which can reassure existing management and shareholders.

Risks

• The filing certifies that the securities were not acquired for the purpose of or with the effect of changing or influencing the control of the issuer, mitigating a potential risk of activist investor engagement.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding Astera Labs Inc.'s future performance or operations.

Industry Context

This filing is a routine regulatory disclosure of an investment firm's stake in a publicly traded company. It reflects a specific investment decision by AllianceBernstein L.P. and does not provide broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake and confirms the investment purpose is not for control, which can reduce uncertainty.

Key Dates

Keywords

Astera Labs Inc, AllianceBernstein L.P., Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, Schedule 13G, Institutional Ownership